120
Participants
Start Date
December 13, 2016
Primary Completion Date
June 22, 2018
Study Completion Date
June 22, 2018
Dabigatran etexilate
Warfarin
Vivantes Netzwerk für Gesundheit GmbH, Berlin
Fondazione Centro San Raffaele del Monte Tabor, Milan
A. O. Ospedale Circolo Fond. Macchi, Varese
Asklepios Klinik Wandsbek, Hamburg
ASST di Cremona, Cremona
Hospital Ramón y Cajal, Madrid
Hospital La Paz, Madrid
HOP Pellegrin, Bordeaux
Nuovo Ospedale Civile S. Agostino-Estense, Modena
Universitätsklinikum Essen AöR, Essen
Universitätsklinikum Heidelberg, Heidelberg
Universitätsklinikum Tübingen, Tübingen
HOP Lariboisière, Paris
University Clinical Center, Gdansk, Gdansk
Copernicus Med.Company.Ltd,Hosp.Nicolaus, Gdansk, Gdansk
All India Institute of Medical Sciences, New Delhi
St.Petersb,State Hlthcare Instit. Elisabeth Hosp,Neurol.dept, Saint Petersburg
Sahyadri Speciality Hospital, Pune
Interreg. Clinical & Diagnostic Center, Neurol. Dept., Kazan, Kazan'
Magnum Heart Institute, Nashik
Nizam's Institute of Medical Sciences, Hyderabad
Mazumdar Shaw Medical centre, Bangalore
Sverdlovsk Reg.Clin.Hosp.No.1, Yekaterinburg
Reg.State Budget Hlthcare,City Hosp#5,Neurology Dept,Barnaul, Barnaul
Caritas Hospital, Kottayam
A.O. San Camillo Forlanini, Roma
Umberto I Pol. di Roma-Università di Roma La Sapienza, Roma
Academisch Medisch Centrum (AMC), Amsterdam
Universitair Medisch Centrum Utrecht, Utrecht
Independent Public Clin.Hospital No.4,Neurol.Dept,Lublin, Lublin
Psychiatry&Neurol.Instit.Interv.Stroke&Cerebrov.Treatm.Cntr, Warsaw
Hospital Fernando Fonseca, EPE, Amadora
CHLO, EPE - Hospital Egas Moniz, Lisbon
CHULN, EPE - Hospital de Santa Maria, Lisbon
Centro Hospitalar São João,EPE, Porto
Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião, Santa Maria da Feira
Lead Sponsor
Boehringer Ingelheim
INDUSTRY